Navigation Links
FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
Date:6/27/2008

CONCERTA(R) now available for patients with ADHD ages 6 to 65

RARITAN, N.J., June 27 /PRNewswire/ -- ADHD is the most common emotional, cognitive and behavioral disorder treated in children(1), and according to the National Institute of Mental Health (NIMH), between 30 percent and 70 percent of children with ADHD continue to exhibit symptoms in the adult years(2). ADHD is thought to affect about eight million, or one in 20, adults in the United States(3), and research on the life span of the condition notes the disorder impairs academic, social and occupational functioning(1), and is associated with academic underachievement, conduct problems, underemployment, motor vehicle safety and difficulties with personal relationships(1).

Today, there's a new treatment option for the millions of adults in the United States with ADHD: Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) announced the U.S. Food and Drug Administration (FDA) approved J&JPRD's Supplemental New Drug Application (sNDA) for CONCERTA(R) treatment of ADHD in adults ages 18 to 65. The doses approved for adults range from 18 to 72 mg daily.

Today's approval expands the CONCERTA(R) indication from children and adolescents into adults with ADHD, and offers these patients a patented once- daily formulation. Using its unique OROS(R) delivery system, the CONCERTA(R) formulation delivers an initial dose of medication when the tablet is ingested. Medication is then delivered into the bloodstream at a controlled rate throughout the day.

The CONCERTA(R) brand, which was the first 12-hour extended-release methylphenidate (MPH) treatment for ADHD, is the market leader for MPH treatment of children and adolescents with ADHD. CONCERTA(R) is marketed in the United States by McNeil Pediatrics(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

"What we've seen in the growing body of knowledge on adult ADHD suggests a challenging burden of impairme
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & DevelopmentL.L.C.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics Unique Proprietary Chemistry
2. Big Win for Biodiesel: ASTM Approves New Biodiesel Blend Specifications
3. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
4. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
5. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
6. FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
7. Maryland Approves Medicaid Reimbursement for ActiPatch(R)
8. Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care
9. Medicare Approves in Home Sleep Apnea Testing
10. 3SBio Inc. Approves Share Repurchase Program
11. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...W YORK, Nov. 25 Reportlinker.com a...lable in its catalogue: ,, Brazil Bioethanol M...//www.reportlinker.com/p0165503/Brazil-Bioethanol-...Brazil Bioethanol Market Analysis and Forecasts to...tailed analysis and forecasts of the global bioeth...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...Who: David Appia, French Ambassador for Internatio... in France Agency, , , , ,What: Ambassador Appia ...pro-business initiatives adopted by France to furt...dscape for innovation and development., , ,When: A...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced that it has received notice f...mpany,s common stock will be,suspended as of Novem...the,Securities and Exchange Commission, which will...aq, unless the company files an appeal to the Nasd...
(Date:11/24/2009)...HANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmace...rk Office (PTO) has allowed the patent application...logy. , NOD technology is a highly effici...nto bio-adhesive nano-particles to enable oral del...s. NOD technology is a platform technology,that ca...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...dingBlocks is market,s first service for pre-purch..., Dec. 9 The Scientific business of Thomson Reute... source for online access to industry codes and st... BuildingBlocks utility, allowing engineers to pre...hers such as ASTM (American Society for Testing a...
...H SAN FRANCISCO, Calif., Dec. 9 Proteolix, Inc. t...g that the company,s lead,product, carfilzomib, ha...nses,in patients with relapsed and refractory mult...lass of specific proteasome inhibitors being devel... malignancies and solid tumors. , Sundar Jag...
...TO, Calif., Dec. 9 BioMarin Pharmaceutical,Inc. (...Merck Serono, a division,of Merck KGaA, Darmstadt,...n(R) (sapropterin dihydrochloride) for the treatme...ia (PKU) or BH4 deficient patients,from the Europe...are,approximately 35,000 patients diagnosed with h...
Other Biology Technology:Techstreet Launches BuildingBlocks Utility for Industry Standards Saving Time and Increasing Productivity for Engineers 2Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 2Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 3Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 4Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 5Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 6Kuvan Receives Marketing Approval in the European Union 2Kuvan Receives Marketing Approval in the European Union 3Kuvan Receives Marketing Approval in the European Union 4
(Date:11/24/2009)...arctica has long held secrets of the earth,s histo...here has been very little information on the envir... for millions of years. Now, a team of researchers...funded to the tune of $10 million dollars by the N...bottom of things literally. These scientists will...
(Date:11/24/2009)...vember 24, 2009) New research on bacterial commun... reveals predictable temporal patterns, suggesting...rkers for monitoring climate change in the polar r...ceedings of the National Academy of Sciences Earl... six rivers shifted synchronously over time, corre...
(Date:11/23/2009)...arch presents strong evidence that the "synergisti...raffic-related pollution and indoor endotoxin caus...ther exposure alone. , Environmental health sc...ege of Medicine have shown that children exposed t...d indoor endotoxin during early life are six times...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 1Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 2As Good As a Deli For the Price of Making It At Home 52824 1As Good As a Deli For the Price of Making It At Home 52824 2Molecule plays early role in nonsmoking lung cancer 52821 1Molecule plays early role in nonsmoking lung cancer 52821 2
...that interfere with the action of one particular e...roblems led scientists at Johns Hopkins to create ...w them to see multiple, real-time chemical reacti...ublished July 21 in the journal ACS Chemical Biolo...est chemicals on enzymes isolated from their norma...
...enetic material intact, scientists at Johns Hopkin... vital to managing a yeast cell,s energy. They dis...l of one of them led the cell to turn off 70 perce...ely unprepared for such a dramatic event," says Je...ology and genetics at Hopkins and author of the st...
...ads of Earthlings, arrays of single-cell creatures...le devices are riding on the International Space S...nd the University of New Mexico, NASA and US Air F...ons were directed by yeast and other single cells ... even in the vacuum and radiation of outer space -...
Other Biology News:Hopkins researchers develop new tool to watch real-time chemical activity in cells 2Hopkins researchers develop new tool to watch real-time chemical activity in cells 3Johns hopkins researchers find link between cell's energy use and genome health 2Johns hopkins researchers find link between cell's energy use and genome health 3Sandia work launched on space shuttle shows live cells influence growth of nanostructures 2Sandia work launched on space shuttle shows live cells influence growth of nanostructures 3Sandia work launched on space shuttle shows live cells influence growth of nanostructures 4Sandia work launched on space shuttle shows live cells influence growth of nanostructures 5
Fingerprinting II Dimensioning Techniques from Bio-Rad
Fingerprinting II Informatix Dimensioning Techniques from Bio-Rad
DNA Engine Opticon 2 Continuous Fluorescence Detection System from Bio-Rad
Fingerprinting II Comparative Quantification and Polymorphism Analysis from Bio-Rad
Biology Products: